| Hospice Of Havasu, Inc. 365 South Lake Havasu Avenue, Lake Havasu City, AZ, 86403 | |
| (928) 453-2111 |
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| Name | Hospice Of Havasu, Inc. |
|---|---|
| Location | 365 South Lake Havasu Avenue, Lake Havasu City, Arizona |
| Hospice ID | 031543 |
| Category | Freestanding Hospice |
| Ownership Type | Voluntary Non-profit - Private |
| Profit Type | NON-PROFIT |
| SSA county code | 070 |
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| NPI Number | 1255513578 |
| Organization Name | Hospice Of Havasu, Inc. |
| Address | 150351 Del Rey Drive Big River, California, 92242 |
| Phone Number | (928)453-2111 |
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| NPI Number | 1649254517 |
| Organization Name | Hospice Of Havasu, Inc. |
| Address | 365 Lake Havasu Ave S Lake Havasu City, Arizona, 86403 |
| Phone Number | (928)453-2111 |
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 96.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 73.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.5 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 57.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 97.7 | 97.3 |
| Patients who got timely treatment for shortness of breath | 94.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 86.8 | 93.3 |
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| Home Health Aides | 16.1 |
| Counselors | 5 |
| Licensed Practical or Vocational Nurses | 5 |
| Medical Social Workers | 8.2 |
| Physicians | 0.55 |
| Registered Nurses | 25.6 |
| Other Personnel | 34.65 |
| Total Employees | 95.1 |
|---|
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| Others | 5.9 |
| Total Volunteers | 5.9 |
|---|
News Archive
Therapeutic cancer vaccines were first developed 100 years ago and have remained broadly ineffective to date. Before tangible results can be achieved, two major obstacles must be overcome.
NextGen Group plc is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has completed a commercial reorganization. The restructuring, which is accompanied by new management appointments, is expected to help the company execute its strategy of becoming a leading player in the growing oncology and central nervous system (CNS) biomarker markets.
Palomar Medical Technologies, Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced financial results for the third quarter ended September 30, 2010. Revenues for the quarter ended September 30, 2010 increased to $15.8 million, as compared to $14.5 million reported in the third quarter of 2009.
The Hearing Loss Clinic, today announced plans for the eight day hearing mission trip to Mombasa, Kisumu, and Nairobi, Kenya projected to result in fitting more than 3,000 adults and children receiving over 6,000 hearing instruments.
Citalopram, a medication commonly prescribed to children with autism spectrum disorders (ASD), was no more effective than a placebo at reducing repetitive behaviors, according to researchers funded by the National Institute of Mental Health (NIMH) and other NIH institutes. The study was published in the June 2009 issue of Archives of General Psychiatry.
› Verified 3 days ago
| Hospice Of Havasu, Inc. Location: 365 South Lake Havasu Avenue, Lake Havasu City, Arizona, 86403 Phone: (928) 453-2111 |